Omniome, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2013

Location

San Diego CA US

Primary Industry

Biotechnology

About

Founded in 2013 and based in California, US, Omniome, Inc. is a biotechnology company that develops DNA sequencing technologies for cancer diagnostics. The company was founded by Kandaswamy Vijayan. In 2019, Omniome, Inc. raised USD 60 million in Series C funding led by new investor Madrone Capital Partners, with participation from existing investors. In July 2021, Pacific Biosciences of California, Inc. signed a definitive agreement to acquire Omniome, Inc. The company offers a DNA sequencing technology for cancer diagnostics that delivers accurate sequencing. It also operates Sequencing By Binding (SBB) technology, a solution that enhances the precision of nucleotide and DNA matching. The company's revenue is generated by the sales of its DNA sequencing solution to its target market for industries engaged in clinical sequencing. The acquisition of Pacific Biosciences of California, Inc. by Omniome, Inc. will help in the expansion of its technology to a wider market range.

Current Investors

Domain Venture Partners PPC, Altitude Life Science Ventures, Biomatics Capital Partners

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment

Website

www.omniome.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.